1

Berkeley Doctor Claims People Die From Chemotherapy, Not Cancer [Watch]

Credit: healthawarenessforall.com

Credit: healthawarenessforall.com

Amanda Froelich | True Activist

People who refuse chemotherapy treatment live on average 12 and a half years longer than people who undergo chemotherapy, says Dr. Jones.

According to recent statistics, approximately 1 in 2 men and 1 in 3 women will develop cancer in their lifetimes. This saddening reality is made worse when it is acknowledged that modern methods of ‘treating’ the disease are often ineffective and only make the symptoms of the disease worse. In fact, according to one Berkeley doctor, chemotherapy doesn’t work 97% of the time.

In the eye-opening video above, Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, discusses how ‘leading edge’ cancer treatment is a sham.

He has personally studied the life expectancy of patients for more than 25 years and has come to the conclusion that chemotherapy does more harm than good. The bone-chilling realization prompted Dr. Jones to speak out against the billion-dollar cancer industry.

“People who refused chemotherapy treatment live on average 12 and a half years longer than people who are undergoing chemotherapy,” said Dr. Jones of his study, which was published in the New York Academy of Science.

“People who accepted chemotherapy die within three years of diagnosis, a large number dies immediately after a few weeks.” 

According to the physician, the only reason doctors prescribe chemotherapy is because they make money from it. Such an accusation doesn’t seem unreasonable, as cancer treatment runs, on average, between $300,000 – $1,000,000 per treatment.

Credit: healthawarenessforall.com

Credit: healthawarenessforall.com

 “Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. So this is something that you will not hear in the mass media, which will continue to carry the myth that the best chemotherapy drug in the fight against cancer!”

Despite the fact that the United States spends more on healthcare than any other high-income nation in the world, diseases of affluence continue to increase in prevalence, resulting in a shorter life expectancy.

Perhaps this is because mainstream media and the allopathic healthcare system don’t teach about the importance of preventative medicine. Eating a healthy diet, engaging in exercise, thinking positive thoughts, reducing stress, and enjoying the company of others – or habits that bring joy – are all proven to improve longevity and happiness.

In addition, potent all-natural medicines, such as cannabis oil, are also strictly regulated and illegal in many areas – despite the fact that CBD-rich oil from the marijuana plant is listed as a remedy on the U.S.’ National Cancer Institute’s website.

As it is, there is no money in a healthy population, which is why fast food joints and pharmaceutical industries thrive in America. Hopefully, Dr. Jones’ efforts will inspire people to seek out alternative options if they or someone they know develops the debilitating disease.

What are your thoughts? Please comment below and share this news! 


This article (Berkeley Doctor Claims People Die From Chemotherapy, Not Cancer [Watch]) is a free and open source. You have permission to republish this article under a Creative Commons license with attribution to the author and TrueActivist.com

Read more great articles at True Activist.




Yet Another Study (from a Medical Journal) Says Chemo Is Making Cancer Worse

By Dave Mihalovic | Prevent Disease 

Yet another new study published in Science Translational Medicine shows that chemotherapy promotes cancer metastasis.

Cancers figure among the leading causes of morbidity and mortality worldwide. Between 2005 and 2015, cancer cases increased by 33 percent and the number of new cases is expected to rise by about 70% over the next just two decades under the current global disease promoting paradigm.

A 14-year study published in the Journal of Clinical Oncology in December 2004 called “The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies” showed that the overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1 % in The USA.

Breast cancer is one of the most prevalent forms of cancer and the idea that while trying to make it better we are actually making it WORSE is undoubtedly terrifying for everyone.

Related Article: The True History of Chemotherapy & The Pharmaceutical Monopoly

Researchers tested the effects of a type of chemotherapy on tissue collected from men with prostate cancer, and found “evidence of DNA damage” in healthy cells after treatment, the scientists wrote in Nature Medicine. The scientists found that healthy cells damaged by chemotherapy secreted more of a protein called WNT16B which boosts cancer cell survival.

Science Translational Medicine Study

Neoadjuvant chemotherapy is the first line of medical intervention against breast cancer — it is the first treatment prescribed to patients who are diagnosed with the disease. Usually, the strategy is to use the poison to shrink the tumor before surgery, when the bulk of the cancer is cut off.

Cancer cells are different from every other cell type in the body because they are dividing very quickly and uncontrollably. Chemotherapy harms other cells in the body that also divide quickly — such as cells in the hair follicles, which is why chemo patients often lose their hair. However, the main tumor body is not necessarily the most dangerous aspect of cancer. 90% of patients that pass away from cancer do so because the cancer has spread throughout the body to other organs and tissues. For example, breast cancer cells can get into the bloodstream and get transported to the bones, to the lungs and to the liver. This process in known as metastasis and is unquestionably the most dangerous side of cancer. Unfortunately, in many cases after the cancer is removed and the patient undergoes more chemotherapy there will be signs that some cancer cells have escaped the surgery and have started growing elsewhere. It might take a long time — even decades is some cases, but metastasis is sadly a very common occurrence.

The authors of the study in STM use an interesting and relatively novel marker of metastasis which is called tumor microenvironment of metastasis — TMEM for short. Each TMEM site is a spot where cancer cells are likely to make a transition between the tissue they are from and the bloodstream — which acts as a very effective transportation system to carry cancer cells throughout the body. Ingeniously, in this particular piece of research scientists use three molecules that are known to be very highly present at TMEM sites. Therefore, counting the number of spots where these molecules are highly expressed is a by-proxy way of measuring how many opportunities breast cancer cells have to make that fatal move out of the breast tissue and into the bloodstream. The study also shows that neoadjuvant chemotherapy increases the number of TMEM sites — which means there is an increased risk for cancer cells to metastasize. Given these data it is unsurprising that in the mice that are used as a model in this study the use of chemotherapy leads to an increased amount of metastasis.

Related Article: Mindboggling: UK Doctors Destroy Breast Cancer Tumors in Just 11 Days — WITHOUT Chemotherapy

Peter Glidden, BS, ND in the video above describes the 12-year meta-analysis published in the Journal of Clinical Oncology which observed adults who had developed cancer and treated with chemotherapy. The 12-year study looked at adults who had developed cancer as an adult.

Read more great articles at Prevent Disease.